<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author>Кондратенко, Р.М.</author>
     <author>Балтина, Л.А.</author>
     <author>Васильева, Е.В.</author>
     <author>Насыров, Х.М.</author>
     <author>Киреева, Р.М.</author>
     <author>Басченко, Н.Ж.</author>
     <author>Фридман, С.М.</author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
    </authors>
   </contributors>
   <titles>
    <title>СИНТЕЗ И ИММУНОМОДЕЛИРУЮЩАЯ АКТИВНОСТЬ НОВЫХ ДИГЛИКОПЕПТИДОВ ГЛИЗИРРИЗИНОВОЙ КИСЛОТЫ И ЕЕ 30-МЕТИЛОВОГО ЭФИРА</title>
   </titles>
   <dates>
    <year>2004</year>
    <pub-dates>
     <date>2018-01-19</date>
    </pub-dates>
   </dates>
   <abstract>New amino acid derivatives of glycyrrhizic acid and its methyl ester were selectively synthesized using active&#13;
/V-succinimide esters. The compounds with residues of glycine ethyl ester and alanine methyl and butyl esters&#13;
increased the level of agglutinins and hemolysins in blood serum of mice two- to threefold in comparison with&#13;
the control upon parenteral administration at a dose of 2 mg/kg for 14 days.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/633</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/698</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
